Which increases the risk for neuroleptic malignant syndrome (NMS)?
•
4 min read
Though rare, with an incidence estimated between 0.01% and 0.03% among patients taking antipsychotics, neuroleptic malignant syndrome (NMS) is a life-threatening medical emergency. Understanding which factors increase the risk for neuroleptic malignant syndrome (NMS) is crucial for both healthcare providers and patients to facilitate prompt recognition and management.
